Well Being: Antalgic Effects of Well-being Treatments in Cancer Care

Sponsor
Centre Hospitalier de Valence (Other)
Overall Status
Completed
CT.gov ID
NCT05493150
Collaborator
(none)
180
1
23.3
7.7

Study Details

Study Description

Brief Summary

observational , Monocentric, study to assess antalgic effects of well-being treatment in cancer care.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Contrary to supportive care, well-being care is imperfectly assessed. Well being care (WBC) consist on complementary programs, with no real consensus. Very few studies have rigorously evaluated its benefits

    The objective of this study was to evaluate the impact of four well-being treatments (foot reflexology, socio-aesthetics, Sophrology and singing) provided in a healthcare facility

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    180 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Antalgic Effects of Well-being Treatments in Cancer Care; Foot Reflexology, Socio-aesthetics, Sophrology, Singing
    Actual Study Start Date :
    Jan 22, 2020
    Actual Primary Completion Date :
    Sep 30, 2021
    Actual Study Completion Date :
    Dec 30, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Pain assesment [1 immediately before well being treatment]

      numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."

    2. Pain assesment [1 immediately after well being treatment]

      numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • all type of cancer treated at the general Hospital of Valence

    • patient agree to participate on Well being session: foot reflexology, socio-aesthetics, Sophrology and singing

    • Age ≥ 18 years

    • Affiliation to a Social security system

    • Patient who has given written consent signed before any specific procedure of the protocol

    Exclusion Criteria:
    • Patient under guardianship, deprived of liberty, safeguard of justice

    • Patient presenting a serious psychiatric pathology that does not allow compliance with the completion of the scale (at the discretion of the investigator)

    • Refusal to participate in research

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ch Valence Valence Drome France 26953

    Sponsors and Collaborators

    • Centre Hospitalier de Valence

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier de Valence
    ClinicalTrials.gov Identifier:
    NCT05493150
    Other Study ID Numbers:
    • 00006
    First Posted:
    Aug 9, 2022
    Last Update Posted:
    Aug 9, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 9, 2022